Diabetes and weight loss drugs shown to reduce alcohol-related hospitalizations, study finds

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcohol effects, a new study suggests.

Glucagon-like peptide-1 receptor (GLP-1) agonists — which contain either semaglutide or liraglutide — are prescribed to treat type 2 diabetes and obesity, but previous studies have shown that people report decreased alcohol consumption when taking them.

In a new study by the University of Eastern Finland and Karolinska Institutet in Sweden, researchers found that people with alcohol...